West Pharmaceutical Services (WST) Debt Ratio (2009 - 2026)

West Pharmaceutical Services (WST) has reported Debt Ratio for 18 consecutive years, with 0.05 the latest figure, recorded in Q2 2026.

• Quarterly Debt Ratio fell 2.89% year-over-year to 0.05 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.05 (down 2.89% YoY) and the FY2025 annual result came in at 0.05, down 14.59% from the prior year.
• Debt Ratio grew to 0.05 in Q2 2026 per WST's latest filing, from 0.05 in the prior quarter.
• Over the last five years, Debt Ratio for WST reached as high as 0.08 in Q1 2022 and fell as low as 0.05 in Q4 2025.
• A 5-year average of 0.06 and a median of 0.06 in 2025 frame the typical range for Debt Ratio.
• Annual changes were most pronounced in 2022 — Debt Ratio slumped 35.6% — and 2024, when it climbed 3.06%.
• Year by year, Debt Ratio stood at 0.06 in 2022, then slipped by 6.5% to 0.05 in 2023, then gained by 2.97% to 0.06 in 2024, then declined by 14.59% to 0.05 in 2025, then climbed by 4.8% to 0.05 in 2026.
• According to Business Quant data, Debt Ratio over the past three periods registered 0.05, 0.05, and 0.05 for Q2 2026, Q1 2026, and Q4 2025 respectively.